Our Eden Valley Hospice team have supported:
- CHELsea II trial – The aim of the CHELsea II trial is to assess whether giving patients in the last days of life fluids via a drip (“clinically-assisted hydration”, CAH) is effective at preventing them from developing delirium (“terminal agitation”) and is led by the University of Surrey. You can read more here: https://www.surrey.ac.uk/chelsea-ii-trial
- We took part in Thrombosis Research in 2021 which formed part of a national published paper and included contributions and credits from Dr Teresa Storr and Dr Sarah Stevenson and Eden Valley Hospice. You can read more here: https://pubmed.ncbi.nlm.nih.gov/36738665/ (Looking at the prevention of hospital associated thrombosis in palliative care remains controversial yet many countries recommend the documented risk assessment and where appropriate pharmacological prophylaxis of inpatients with advanced cancer.)
- Members of our clinical team are also taking part in interviews for a Lancaster University Research Study looking at sedation at the end of life (Spring 2025).
Our leadership team have supported:
- A University of Northumbria-led PhD study into the impact of collaborative leadership looking at the role of governance in facilitating a place-based approach to health and social care.
- Worked with the University of Lancaster to support MBA student Aniket Deshpande to review our carbon footprint and sustainability challenges. It was supported by the Centre for Global Eco-Innovation’s ECO-I NW Programme funded through the European Regional Development Fund and the Northern Powerhouse.
Find out more about adjoining Jigsaw’s, Cumbria’s Children’s Hospice, research projects here.